A legal entity created on a voluntary basis and engaged in a certain business, company can operate in different market and counties. A company size is measured on the basis of its market value, sales, assets or profits. As a rule, companies are represented by the following types: be private, public, government, unlimited, foreign, producer, to name a few. Typical departments found in almost any company comprise but are not limited to production, customer services, marketing, human resources, finance, to name a few.
Exxon Mobil, JPMorgan Chase, Shell, Apple, Royal Dutch Shell and Toyota Motor are amidst the globe’s largest and most influential companies, with most of them active the world over.
This Catalogue’s research reports cover companies involved in various business activities, be it production, sales, marketing, etc. The reports contain information on companies’ activities, historical development, key executives, departments, product offerings. SWOT analyses, data on market share, marketing strategies, the most recent activities within the industry, acquisitions, strategic partnerships and alliances are included in the research reports.
Publications found:
193,061
Sort by:
Textron Inc. - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
EADS N.V. - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
Thales S.A. - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
Daimler AG - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
Volvo AB - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
Scania AB - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
PACCAR Inc. - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
Iveco S.p.A. - Strategic Snapshot & SWOT Analysis - Q4 2011
US$ 150.00
SWOT Analysis is a framework used extensively for an assessment of the internal as well as external business environment as part of the strategic or corporate planning process. The framework generates...
October 2011
15 pages
The Coca-Cola Company in Health and Wellness (World)
US$ 572.00
The Coca-Cola Company (TCCC) has not made any large-scale health and wellness (HW) acquisitions in 2009-2010, with Russia’s Nidan and ... Coca-Cola Company in Health and Wellness (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Health and ...
October 2011
40 pages
Biomet Profile (Biomaterials, Large Joints, Small Joints, Spine & Trauma, Dental): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials 2012
US$ 6,995.00
... the globe, earning revenues in the billions. This report is a comprehensive overview of Biomet's business activities with an in-depth analysis of the company's market share and presence in various global orthopedic biomaterial, large joints, small joints, spine & trauma and dental markets. The information ...
October 2011
202 pages
ASTRAZENECA - Seroquel XR: Para IV Settled with Handa, More to come
US$ 90.00
AstraZeneca today announced that it has settled paragraph IV litigation for Seroquel XR with Handa pharmaceuticals, who has the first to filer status ... settlement Handa will launch Seroquel XR generics only after November 2016. While litigation is ongoing with other Para-IV filers and a court decision ...
September 2011
2 pages
V.I.P. Industries Limited -Fundamental Company Report
US$ 60.00
V.I.P. Industries is an Indian company into travel product business. The company manufactures plastic moulded luggage, soft luggage and plastic moulded furnitures. The major brands of the company are...
September 2011
10 pages
V-Guard Industries Limited - Fundamental Company Report
US$ 60.00
V-Guard Industries Limited - Fundamental Company Report Including Financial ,Business,Recent Development,Industry Overview,Competitors and Key Risk AnalysisV-Guard is an Indian company into the design...
September 2011
11 pages
Advanta India Limited Fundamental Company Report
US$ 60.00
Advanta India is a 100% subsidiary of Advanta International Group. It is into the production and commercialization of specialty products, seed and agrochemicals throughout the world. The company,...
September 2011
10 pages
Hotel Leela Venture Ltd - Fundamental Company Report
US$ 60.00
Hotel Leela Venture Ltd - Fundamental Company Report Including Financial ,Business,Recent Development,Industry Overview,Competitors and Key Risk AnalysisHotel Leela Venture Ltd. is part of Rs. 4.50bn...
September 2011
8 pages
The 2011 Leading Chemical Companies Facilities and Employees
US$ 1,480.00
... U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international work force size and distribution development. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 63 pages
September 2011
63 pages
The 2011 Leading Chemical Companies R&D Expenditures and Major Programs
US$ 2,000.00
... company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 44 pages
September 2011
44 pages
The 2011 Leading Chemical Companies Collaborative Arrangements
US$ 1,480.00
... ventures, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 52 pages
September 2011
52 pages
The 2011 Leading Chemical Companies Business Organizations and Senior Management Profiles
US$ 1,480.00
... . Recent acquisitions, divestitures and significant organizational changes. Current organizational structure. Background of key executives. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 125 pages
September 2011
125 pages
The 2011 Leading Orthopedics Companies Collaborative Arrangements
US$ 1,480.00
... ventures, distribution, O.E.M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 42 ...
September 2011
42 pages
The 2011 Leading Orthopedics Companies Product Portfolio Analyses
US$ 1,400.00
Each company's analysis provides: Review of major product lines. Specifications and features of current products. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 158 pages
September 2011
158 pages
Pharmasset - Tapping Both IFN and IFN-Free Opportunities
US$ 140.00
... daily NS5A inhibitor (BMS-790052) +Peg-IFN/RBV. Efficacy data of BMS-790052 raises ... NS5A inhibitor) - Once daily w/o IFN. PSI-7977+ Peg-IFN/RBV have shown advantage over the ... IFN-free combinations. For more details, please read our report released on 21th September, 2011 on VRUS titled “Tapping Both IFN and IFN ...
September 2011
7 pages
ALEXION - Great Expectations From Label Expansion
US$ 140.00
We have a positive expectation for the approval of Eculizumab (L, Soliris, Paroxysmal Nocturnal Hemoglobinuria) in Atypical ... more details, please read our report released on September 16, 2011 on Alexion (ALXN), titled “Great Expectations From Label Expansion”.
September 2011
4 pages
ARQULE - Read-Out Only in 2013
US$ 140.00
... . It is an attractive acquisition target due to…. For more details, please read our report released on 13th September, 2011 on ARQL titled “Read-Out Only in 2013”.
September 2011
4 pages
ARDEA - Entering the Pivotal Phase
US$ 140.00
After a long wait, Ardea (RDEA) reached an agreement with the FDA on the proposed PhIII ... in the report released on 12th September, 2011 on RDEA titled “Entering the Pivotal Phase”. For more details please ask for our initiation ...
September 2011
3 pages
DNA Sequencing: Role in Clinical Laboratories
US$ 680.00
... , detection, gene profiling, and expression, polymorphism, screening, protein interaction networks, and others. Sequencing is expected to continue playing a major role in clinical laboratories, e.g., in detecting resistance mutations in viruses and bacteria, especially because of the rising availability of ...
August 2011
15 pages
